Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00715
|
|||||
Drug Name |
Sulindac
|
|||||
Synonyms |
(E)-(1)-5-Fluoro-2-methyl-1-((4-(methylsulphinyl)phenyl)methylene)-1H-indene-3-acetic acid; (Z)-5-Fluoro-2-methyl-1-((p-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid; (Z)-5-Fluoro-2-methyl-1-[[4-(methyl-sulfinyl)phenyl]methylene]-1H-indene-3-acetic acid; (Z)-5-Fluoro-2-methyl-1-[p-(methylsulfinyl)benzylidene]indene-3-acetic acid; 2-[(3E)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid; 2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid; 2-[6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid; 5-Fluoro-2-methyl-1-((4-(methylsulphinyl)phenyl)methylene)-1H-indene-3-acetic acid; Aclin; Aflodac; Alphapharm Brand of Sulindac; Apo Sulin; Apo-Sulin; Apotex Brand of Sulindac; Arthrobid; Arthrocine; Cahill May Roberts Brand of Sulindac; Chemia Brand of Sulindac; Chibret; Cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid; Cis-5-Fluoro-2-methyl-1-((p-methylsulfinyl)benzylidene)indene-3-acetic acid; Clinoril; Clinoril (TN); Copal; Copal resin; Copal rosin varnish; Copals; Gum copal; Kenalin; KendrickBrand of Sulindac; Klinoril; MK 231; MK-231; MK231; Merck Brand of Sulindac; Merck Sharp & Dohme Brand of Sulindac; Mobilin; Novo Sundac; Novo-Sundac; Novopharm Brand of Sulindac; Nu Pharm Brand of Sulindac; Nu Sulindac; Nu-Pharm Brand of Sulindac; Nu-Sulindac; Resin copal; S 8139; Sulindac (JAN/USP/INN); Sulindac [USAN:BAN:INN:JAN]; Sulindac sulfoxide; Sulindaco; Sulindaco [INN-Spanish]; Sulindacum; Sulindacum [INN-Latin]; Sulindal; Z-5-Fluoro-2-methyl-1-[p-(methlsulfinyl)benzylidene]indene-3-acetic acid; [(1E)-5-fluoro-2-methyl-1-{[4-(methylsulfinyl)phenyl]methylidene}-1H-inden-3-yl]acetic acid; {(1E)-5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid; {(1Z)-5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid; {5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1h-inden-3-yl}acetic acid
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Rheumatoid arthritis [ICD11: FA20] | Approved | [1] | |||
Therapeutic Class |
Antiinflammatory Agents
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C20H17FO3S
|
|||||
Canonical SMILES |
CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
|
|||||
InChI |
InChI=1S/C20H17FO3S/c1-12-17(9-13-3-6-15(7-4-13)25(2)24)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10H,11H2,1-2H3,(H,22,23)/b17-9-
|
|||||
InChIKey |
MLKXDPUZXIRXEP-MFOYZWKCSA-N
|
|||||
CAS Number |
CAS 38194-50-2
|
|||||
Pharmaceutical Properties | Molecular Weight | 356.4 | Topological Polar Surface Area | 73.6 | ||
Heavy Atom Count | 25 | Rotatable Bond Count | 4 | |||
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 5 | |||
XLogP |
3.4
|
|||||
PubChem CID | ||||||
PubChem SID |
103179013
, 103925149
, 104170038
, 104253449
, 110524953
, 11111823
, 11111824
, 11114189
, 11534177
, 118307514
, 121361866
, 121362536
, 14828051
, 17405626
, 26611935
, 26680385
, 26732639
, 26747172
, 26747173
, 32248851
, 46506570
, 4693
, 47216762
, 47736459
, 47959726
, 47959727
, 47959728
, 48035101
, 48035102
, 48259216
, 49699049
, 49982642
, 50106970
, 50106971
, 53778176
, 53789046
, 57409048
, 75972879
, 7847188
, 7980709
, 8149543
, 85231236
, 85787894
, 8653294
, 90341400
, 91011398
, 92124295
, 92303413
, 92307725
, 99301689
|
|||||
ChEBI ID |
ChEBI:9352
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | MRP4 | Transporter Info | Multidrug resistance-associated protein 4 | Substrate | [2] | |
References | ||||||
1 | Sulindac was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
2 | Fluo-cAMP is transported by multidrug resistance-associated protein isoform 4 in rat choroid plexus. J Neurochem. 2010 Oct;115(1):200-8. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.